Home > Insider Trading > Filing (0001209191-22-050535)

Filing Details

Accession Number:: 0001209191-22-050535
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-19 16:51:23
Reporting Period:: 2022-09-19

Accepted Time:: 2022-09-19 16:51:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1923840	Third Harmonic Bio Inc.	THRD	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1708269	Atlas Venture Fund Xi, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1759241	Atlas Venture Opportunity Fund I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780065	Atlas Venture Associates Opportunity I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780066	Atlas Venture Associates Opportunity I, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780067	Atlas Venture Associates Xi, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780068	Atlas Venture Associates Xi, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-19	6,472,374	$0.00	10,013,763	No	4	C	Direct
Common Stock	Acquisiton	2022-09-19	300,000	$17.00	10,313,763	No	4	P	Direct
Common Stock	Acquisiton	2022-09-19	594,096	$0.00	594,096	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2022-09-19	3,541,390	$0.00	3,541,390	$0.00
Common Stock	Series A-2 Preferred Stock	Disposition	2022-09-19	2,282,537	$0.00	2,282,537	$0.00
Common Stock	Series A-3 Preferred Stock	Disposition	2022-09-19	648,447	$0.00	648,447	$0.00
Common Stock	Series B Preferred Stock	Disposition	2022-09-19	594,096	$0.00	594,096	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock, and Series B Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock based on a 1 to 2.259 reverse stock conversion ratio immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any.
On September 19, 2022, Atlas Venture Fund XI purchased 300,000 shares of common stock of the Issuer at a purchase price of $17.00 per share pursuant to an underwritten public offering.
The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.
The balance has been reduced by one share to adjust for an overstatemnet of one share in Reporting Person's Form 3 filed on September 14, 2022.